Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | ABCB1 | P08183 | 10/20 | 0.33 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.33 |
| ▸ | HSF1 | Q00613 | 1/20 | 0.32 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | CASR | P41180 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15536338 | 0.85 | USP2 (0.38) | USP2HTTHSD17B10ABCB1SPHK1 | |
| SCHEMBL9927998 | 0.83 | HSD17B10 (0.38) | USP2HTTHSD17B10SPHK1LPAR5 | |
| SCHEMBL9927994 | 0.83 | USP2 (0.38) | USP2HTTHSD17B10SPHK1LPAR5 | |
| SCHEMBL13484060 | 0.81 | USP2 (0.40) | USP2HTTHSD17B10SPHK1LPAR5 | |
| SCHEMBL61834 | 0.81 | USP2 (0.37) | USP2HTTHSD17B10SPHK1HSF1 | |
| SCHEMBL15255243 | 0.81 | USP2 (0.37) | USP2HTTHSD17B10SPHK1LPAR5 | |
| SCHEMBL61330 | 0.81 | USP2 (0.37) | USP2HTTHSD17B10SPHK1LPAR5 | |
| SCHEMBL16710535 | 0.81 | USP2 (0.40) | USP2HTTHSD17B10SPHK1LPAR5 | |
| SCHEMBL16306570 | 0.81 | LMNA (0.45) | USP2HTTHSD17B10ABCB1SPHK1 | |
| SCHEMBL15582554 | 0.81 | USP2 (0.37) | USP2HTTHSD17B10SPHK1LPAR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2852625-B1 | SILANE GROUPS CONTAINING POLYMER | SIKA TECH AG (CH) | 2019-01-23 | — | — | EP | disclosed |
| US-9714316-B2 | Polymer containing silane groups | SIKA TECHNOLOGY AG (CH) | 2017-07-25 | — | — | US | disclosed |
| US-20150133603-A1 | POLYMER CONTAINING SILANE GROUPS | SIKA TECHNOLOGY AG (CH) | 2015-05-14 | — | — | US | disclosed |
| EP-2852625-A1 | POLYMER CONTAINING SILANE GROUPS | Sika Technology AG (CH) | 2015-04-01 | — | — | EP | disclosed |
| WO-2013174892-A1 | POLYMER CONTAINING SILANE GROUPS | SIKA TECHNOLOGY AG (CH) | 2013-11-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150133603-A1 | POLYMER CONTAINING SILANE GROUPS | HSPH1, EHMT2, EHMT1 | USP2 1815/4885HTT 484/4885HSD17B10 1393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.